Hints and tips:
Related Special Reports
...The New York-based drugmaker filed a trademark application in mid-April for a website and app providing medical information as well as mail-order pharmacy and telehealth services to US patients under the...
...Expanding medical therapies based on Crispr gene-editing globally is “unrealistic” and the sector needs heavy investment to make the technology, which could transform treatment of diseases, accessible to...
...The Medical Research Council has filed a patent application based on the latest work....
...“The biggest barrier is insurance companies,” said Lawrence Honig, a neurologist at New York’s Columbia University Irving Medical Center....
...Even two large Tory counties in the more prosperous south, Hampshire and Kent, have warned of the risk of effective bankruptcy....
...Hacking Inc....
...Although click and bio-orthogonal chemistry are already used in practical applications, “the field is still in its early phase”, Bertozzi added....
...A version of this article was first published by Nikkei Asia on April 19 2023. ©2023 Nikkei Inc. All rights reserved....
...We haven’t built up the kinds of bio defences that we would need against the next pandemic. We don’t have the sort of bio-surveillance diagnostics, breakthroughs and medical countermeasures....
...Constructive Bio, as the start-up is called, is a spinout from the Medical Research Council’s Laboratory of Molecular Biology....
...Standout Intuitive SurgicalO: 7; L: 8; I: 8; Total: 23In collaboration with law firm Yulchon, the South Korean legal team at the international healthcare and medical devices business has created a new compliance...
...Another is Cambrian Bio, also based in New York, which is developing various drugs to target the biological drivers of ageing. Lauber’s enthusiasm for biotech has proven contagious....
...Experimental embryology is advancing rapidly, as scientists learn new methods of manipulating stem cells....
...An application for regulatory approval will be submitted in the autumn, said Pfizer, which is hunting for new ways to boost revenues as sales of Covid-19 vaccines begin to moderate....
...US drug regulators have approved applications by Moderna and BioNTech/Pfizer to release a Covid-19 vaccine that specifically targets the dominant strain of the Omicron coronavirus variant....
...Pfizer and its German partner BioNTech said their application followed FDA guidance to include clinical data from the companies’ previous trials of a bivalent shot developed to target previous Omicron sub...
...Pfizer, which developed its Covid vaccine with German partner BioNTech, delayed an application for emergency authorisation for jabs for pre-school children and younger in February over concerns that a two-dose...
...Fluence Labs is, uh, “a decentralized platform designed to enable the freedom of digital innovation via peer-to-peer applications”....
...The postponement of Tuesday’s meeting of external advisers follows an request by the FDA to Pfizer to accelerate its application for authorisation even though initial clinical data suggested two doses of...
...Novavax is now testing its efficacy against the new Omicron variant....
...US officials said on Wednesday the FDA would continue to consider Merck’s approval application....
...But there are concerns a new wave of the virus could begin as people move indoors during the winter....
...“And new technologies sometimes provide that option. Sometimes they’re right, sometimes they’re not right.”...
...The drug, which is given as an infusion, was approved by US regulators in June, becoming the first new treatment for Alzheimer’s in almost two decades that purports to slow the development of the neurological...
...A panel of top US scientists has recommended approving Moderna’s application to provide third shots of its Covid-19 vaccine, lending some momentum to the US’s booster rollout....
International Edition